AGR3 and breast carcinoma: Its regulation of breast cancer cell migration and adhesion is executed by inducing the phosphorylation of tyrosine kinases such as Src as proved by the experiment that treatment with Dasatinib, a protein kinase inhibitor, remarkably reduces AGR3-dependent migration.